BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 24775812)

  • 1. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
    Krsakova E; Cermak A; Fedorko M
    J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection].
    Palou J; Angulo JC; Ramón de Fata F; García-Tello A; González-Enguita C; Boada A; Sanz M;
    Actas Urol Esp; 2013 Mar; 37(3):147-55. PubMed ID: 22995326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
    Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
    Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
    D'Elia C; Mian C; Hanspeter E; Ladurner C; Palermo SM; Pycha S; Saleh O; Cai T; Spoladore G; Kafka M; Pycha A; Trenti E
    Urol Int; 2019; 103(4):433-438. PubMed ID: 31614361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
    Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
    World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.
    Kisa E; Altug MU; Gurbuz OA; Ozdemir H
    Int Braz J Urol; 2017; 43(6):1068-1074. PubMed ID: 28727372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
    Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
    Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment to: "Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin".
    Jiménez-Pacheco A
    Actas Urol Esp; 2015 Apr; 39(3):137-8. PubMed ID: 25443521
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
    Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
    J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study between tobramicin and tobramicin plus ciprofloxacin in transrectal prostate biopsy prophylaxis].
    Bosquet Sanz M; Gimeno Argente V; Arlandis Guzmán S; Bonillo García MA; Trassierra Villa M; Jiménez Cruz JF
    Actas Urol Esp; 2006 Oct; 30(9):866-70. PubMed ID: 17175926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose versus multiple-dose ciprofloxacin plus metronidazole prophylaxis in transrectal ultrasound-guided biopsy of the prostate: a randomized controlled trial.
    Heidari Bateni Z; Shahrokh H; Salimi H; Safari H; Tabatabai M; Saedi D
    Acta Med Iran; 2014; 52(9):664-70. PubMed ID: 25325203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one-day and five-day regimen.
    Agbugui JO; Obarisiagbon EO; Osaigbovo EO; Osime CO; Akumabor PN
    Niger Postgrad Med J; 2014 Sep; 21(3):213-7. PubMed ID: 25331236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.